For the twelve months ended Jun 26, 2026, Dolby Laboratories reported $1.35B of revenue and $226.18M of net income.
DLB revenue was $305.00M in fiscal Q3 2026 (ended Jun 26, 2026), down 3.3% from a year earlier and down 22.9% from the prior quarter. For the full fiscal 2025 it was $1.35B, up 5.9% from fiscal 2024. Compound annual growth was +3.0% over 5 years and +3.3% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
DLB net income was $28.60M in fiscal Q3 2026 (ended Jun 26, 2026), down 37.9% from a year earlier and down 69.9% from the prior quarter. For the full fiscal 2025 it was $255.02M, down 2.6% from fiscal 2024. Compound annual growth was +2.0% over 5 years and +3.5% over 10 years. It rose in 6 of the last 10 fiscal years.
DLB diluted EPS was $0.30 in fiscal Q3 2026 (ended Jun 26, 2026), down 37.5% from a year earlier and down 69.7% from the prior quarter. For the full fiscal 2025 it was $2.62, down 2.6% from fiscal 2024. Compound annual growth was +3.1% over 5 years and +4.1% over 10 years.
DLB free cash flow was $152.47M in fiscal Q3 2026 (ended Jun 26, 2026), up 148.9% from a year earlier and up 82.7% from the prior quarter. For the full fiscal 2025 it was $435.85M, up 46.6% from fiscal 2024. Compound annual growth was +9.4% over 5 years and +11.1% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
| Line item | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 | Sep 25, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | $1.16B | $1.24B | $1.05B | $1.08B | $1.03B |
| Cost of revenue | $160.13M | $140.50M | $152.57M | $141.36M | $130.03M | $146.50M | $160.85M | $127.56M | $118.53M | $108.98M |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B | $1.02B | $1.08B | $927.04M | $961.65M | $916.76M |
| Research and development | $261.79M | $263.66M | $271.52M | $261.17M | $253.64M | $239.04M | $237.87M | $236.79M | $233.31M | $219.61M |
| Selling, general and admin | $286.53M | $270.39M | $258.48M | $275.31M | $224.16M | $219.75M | $205.43M | $197.42M | $171.69M | $168.85M |
| Operating income | $264.96M | $258.33M | $215.75M | $206.60M | $344.39M | $218.74M | $257.08M | $183.50M | $247.13M | $231.79M |
| Interest expense | - | - | - | $394.0K | $479.0K | $186.0K | $170.0K | $198.0K | $127.0K | $125.0K |
| Pre-tax income | $303.49M | $312.48M | $250.05M | $215.28M | $354.51M | $239.72M | $282.31M | $196.37M | $255.15M | $235.90M |
| Income tax | $46.99M | $48.16M | $48.41M | $31.38M | $36.69M | $8.10M | $26.80M | $154.07M | $48.04M | $49.50M |
| Net income | $255.02M | $261.82M | $200.66M | $184.09M | $310.23M | $231.36M | $255.15M | $41.75M | $206.48M | $185.86M |
| EPS, basic | $2.66 | $2.74 | $2.10 | $1.84 | $3.07 | $2.30 | $2.51 | $0.40 | $2.03 | $1.85 |
| EPS, diluted | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 | $2.44 | $0.39 | $2.00 | $1.81 |
| Diluted shares | 97.5M | 97.3M | 97.7M | 102.0M | 104.6M | 102.9M | 104.6M | 107.0M | 103.3M | 102.4M |
| Line item | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 | Sep 25, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $701.89M | $577.75M | $817.97M | $628.37M | $1.23B | $1.08B | $805.59M | $925.25M | $634.37M | $519.76M |
| Short-term investments | $703.0K | $0 | $139.15M | $189.21M | $38.84M | $46.95M | $119.15M | $178.14M | $247.76M | $121.63M |
| Receivables | $331.10M | $315.46M | $262.25M | $243.59M | $232.61M | $180.34M | $189.12M | $166.13M | $73.75M | $75.69M |
| Inventory | $30.42M | $33.73M | $35.62M | $23.55M | $10.96M | $25.55M | $32.33M | $26.21M | $25.05M | $16.35M |
| Current assets | $1.39B | $1.19B | $1.49B | $1.31B | $1.76B | $1.55B | $1.38B | $1.50B | $1.01B | $759.73M |
| Goodwill | $529.90M | $533.21M | $408.41M | $365.15M | $340.69M | $336.94M | $334.83M | $327.98M | $311.09M | $309.62M |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B | $2.82B | $2.87B | $2.53B | $2.31B |
| Current liabilities | $437.79M | $417.84M | $422.23M | $277.52M | $315.72M | $267.11M | $306.85M | $285.20M | $245.77M | $213.08M |
| Total liabilities | $595.81M | $623.03M | $607.58M | $438.53M | $501.45M | $478.92M | $508.72M | $494.88M | $389.71M | $331.37M |
| Shareholders' equity | $2.62B | $2.49B | $2.37B | $2.25B | $2.60B | $2.44B | $2.31B | $2.37B | $2.40B | $2.23B |
| Line item | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 | Sep 25, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $472.20M | $327.25M | $367.08M | $318.58M | $447.75M | $343.85M | $327.67M | $352.20M | $377.79M | $360.06M |
| Capital expenditures | $36.35M | $30.01M | $30.34M | $47.93M | $54.45M | $66.35M | $96.28M | $72.81M | $99.62M | $100.76M |
| Free cash flow | $435.85M | $297.25M | $336.74M | $270.65M | $393.30M | $277.50M | $231.39M | $279.39M | $278.18M | $259.30M |
| Investing cash flow | -$10.59M | -$286.29M | $54.21M | -$295.94M | -$44.91M | $134.37M | -$56.23M | $78.09M | -$158.03M | -$282.50M |
| Financing cash flow | -$247.24M | -$287.81M | -$236.81M | -$610.56M | -$252.51M | -$207.78M | -$385.28M | -$133.63M | -$106.83M | -$91.99M |
| Dividends paid | $126.60M | $114.58M | $103.41M | $100.07M | $89.17M | $88.58M | $77.50M | $66.16M | $57.06M | $48.40M |
| Share repurchases | $124.99M | $160.00M | $149.28M | $530.49M | $245.86M | $173.74M | $340.58M | $150.47M | $100.00M | $100.85M |
| Stock-based compensation | $128.51M | $119.83M | $118.49M | $114.92M | $99.70M | $86.63M | $76.58M | $71.25M | $65.34M | $66.98M |
| Depreciation and amortization | $87.83M | $75.56M | $82.56M | $88.46M | $95.86M | $90.88M | $85.12M | $81.28M | $84.31M | $85.15M |
| Line item | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 | Sep 25, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 5.9% | -2.0% | 3.7% | -2.1% | 10.3% | -6.4% | 17.7% | -2.4% | 5.3% | 5.7% |
| Net income growth, YoY | -2.6% | 30.5% | 9.0% | -40.7% | 34.1% | -9.3% | 511.2% | -79.8% | 11.1% | 2.5% |
| EPS growth, YoY | -2.6% | 31.2% | 13.3% | -39.1% | 32.0% | -7.8% | 525.6% | -80.5% | 10.5% | 3.4% |
| Gross margin | 88.1% | 89.0% | 88.3% | 88.7% | 89.9% | 87.4% | 87.0% | 87.9% | 89.0% | 89.4% |
| Operating margin | 19.6% | 20.3% | 16.6% | 16.5% | 26.9% | 18.8% | 20.7% | 17.4% | 22.9% | 22.6% |
| Net margin | 18.9% | 20.6% | 15.4% | 14.7% | 24.2% | 19.9% | 20.5% | 4.0% | 19.1% | 18.1% |
| Free cash flow margin | 32.3% | 23.3% | 25.9% | 21.6% | 30.7% | 23.9% | 18.6% | 26.5% | 25.8% | 25.3% |
| Return on equity | 9.7% | 10.5% | 8.5% | 8.2% | 11.9% | 9.5% | 11.0% | 1.8% | 8.6% | 8.3% |
| Return on assets | 7.9% | 8.4% | 6.7% | 6.8% | 10.0% | 7.9% | 9.0% | 1.5% | 8.1% | 8.0% |
| Current ratio | 3.17 | 2.86 | 3.52 | 4.72 | 5.58 | 5.79 | 4.50 | 5.25 | 4.12 | 3.57 |
| Line item | Jun 26, 2026 | Mar 27, 2026 | Dec 26, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 28, 2025 | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.00M | $395.63M | $346.71M | $307.02M | $315.55M | $369.56M | $357.00M | $304.81M | $288.82M | $364.52M | $315.57M | $290.56M |
| Cost of revenue | $40.32M | $44.73M | $43.21M | $39.52M | $44.00M | $35.84M | $40.77M | $34.00M | $35.66M | $38.78M | $32.06M | $35.55M |
| Gross profit | $264.68M | $350.90M | $303.50M | $267.50M | $271.54M | $333.72M | $316.23M | $270.81M | $253.16M | $325.75M | $283.51M | $255.01M |
| Research and development | $65.75M | $63.65M | $69.08M | $67.47M | $65.98M | $61.71M | $66.64M | $68.64M | $65.50M | $62.49M | $67.03M | $70.43M |
| Selling, general and admin | $75.58M | $75.95M | $70.24M | $73.72M | $72.31M | $70.42M | $70.09M | $69.21M | $69.28M | $66.74M | $65.17M | $66.61M |
| Operating income | $34.32M | $112.95M | $62.16M | $29.68M | $47.64M | $107.76M | $79.88M | $46.35M | $36.78M | $108.97M | $66.22M | -$3.49M |
| Pre-tax income | $43.80M | $119.70M | $71.60M | $41.67M | $55.52M | $120.25M | $86.05M | $59.73M | $50.16M | $121.75M | $80.83M | $9.03M |
| Income tax | $14.59M | $24.25M | $17.92M | -$8.01M | $8.97M | $28.02M | $17.98M | $868.0K | $10.51M | $23.53M | $13.25M | -$875.0K |
| Net income | $28.60M | $94.92M | $53.33M | $49.33M | $46.07M | $91.79M | $67.82M | $58.57M | $38.44M | $97.83M | $66.98M | $9.19M |
| EPS, basic | $0.30 | $1.00 | $0.56 | $0.52 | $0.48 | $0.95 | $0.71 | $0.62 | $0.40 | $1.02 | $0.70 | $0.10 |
| EPS, diluted | $0.30 | $0.99 | $0.55 | $0.50 | $0.48 | $0.94 | $0.70 | $0.59 | $0.40 | $1.01 | $0.69 | $0.08 |
| Diluted shares | 94.5M | 95.5M | 96.5M | - | 96.9M | 97.5M | 97.1M | - | 97.0M | 96.9M | 97.4M | - |
| Line item | Jun 26, 2026 | Mar 27, 2026 | Dec 26, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 28, 2025 | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $669.39M | $594.28M | $643.85M | $701.89M | $756.56M | $750.34M | $611.66M | $577.75M | $778.62M | $824.36M | $708.66M | $817.97M |
| Short-term investments | $652.0K | $460.0K | $739.0K | $703.0K | $763.0K | - | - | $0 | $127.32M | $115.86M | $140.82M | $139.15M |
| Receivables | $285.15M | $391.29M | $373.09M | $331.10M | $297.61M | $314.11M | $339.30M | $315.46M | $285.84M | $282.13M | $293.23M | $262.25M |
| Inventory | $30.77M | $31.93M | $31.26M | $30.42M | $32.41M | $34.59M | $31.83M | $33.73M | $34.72M | $35.80M | $37.57M | $35.62M |
| Current assets | $1.33B | $1.41B | $1.41B | $1.39B | $1.34B | $1.39B | $1.29B | $1.19B | $1.47B | $1.55B | $1.45B | $1.49B |
| Goodwill | $528.34M | $529.67M | $530.30M | $529.90M | $528.82M | $525.02M | $520.42M | $533.21M | $408.46M | $408.65M | $410.44M | $408.41M |
| Total assets | $3.16B | $3.25B | $3.19B | $3.23B | $3.20B | $3.23B | $3.16B | $3.11B | $2.97B | $3.04B | $2.94B | $2.98B |
| Current liabilities | $416.33M | $474.61M | $443.51M | $437.79M | $388.79M | $457.49M | $441.88M | $417.84M | $354.54M | $442.90M | $394.10M | $422.23M |
| Total liabilities | $563.89M | $622.36M | $589.25M | $595.81M | $581.75M | $646.02M | $641.57M | $623.03M | $526.20M | $607.04M | $573.22M | $607.58M |
| Shareholders' equity | $2.58B | $2.63B | $2.60B | $2.62B | $2.61B | $2.58B | $2.52B | $2.49B | $2.45B | $2.44B | $2.36B | $2.37B |
| Line item | Jun 26, 2026 | Mar 27, 2026 | Dec 26, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 28, 2025 | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $167.46M | $92.51M | $54.80M | $122.83M | $67.69M | $174.90M | $106.78M | $116.17M | $21.26M | $181.41M | $8.41M | $85.02M |
| Capital expenditures | $14.99M | $9.06M | $4.63M | $16.24M | $6.43M | $6.90M | $6.78M | $7.38M | $7.61M | $8.92M | $6.10M | $8.19M |
| Free cash flow | $152.47M | $83.44M | $50.17M | $106.59M | $61.26M | $168.00M | $100.00M | $108.79M | $13.65M | $172.49M | $2.31M | $76.83M |
| Investing cash flow | -$9.79M | -$46.09M | $1.25M | -$21.91M | -$6.43M | $25.89M | -$8.14M | -$261.31M | -$7.74M | -$17.87M | $633.0K | -$19.71M |
| Financing cash flow | -$91.02M | -$99.88M | -$121.83M | -$64.06M | -$60.74M | -$64.87M | -$57.57M | -$60.12M | -$58.40M | -$44.16M | -$125.14M | -$42.80M |
| Dividends paid | $33.98M | $34.34M | $34.34M | $31.59M | $31.63M | $31.83M | $31.55M | $28.61M | $28.70M | $28.72M | $28.55M | $25.82M |
| Share repurchases | $65.00M | $65.00M | $70.00M | $35.00M | $70.00M | $35.00M | $15.00M | $20.00M | $35.00M | $25.00M | $80.00M | $25.00M |
| Stock-based compensation | $30.96M | $30.71M | $37.21M | $31.05M | $30.73M | $30.66M | $36.07M | $29.68M | $29.34M | $28.91M | $31.89M | $28.20M |
| Depreciation and amortization | $22.60M | $24.10M | $24.14M | $22.00M | $21.93M | $21.54M | $22.36M | $21.36M | $18.31M | $18.02M | $17.87M | $21.13M |
| Line item | Jun 26, 2026 | Mar 27, 2026 | Dec 26, 2025 | Sep 26, 2025 | Jun 27, 2025 | Mar 28, 2025 | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -3.3% | 7.1% | -2.9% | 0.7% | 9.3% | 1.4% | 13.1% | 4.9% | -3.2% | -3.0% | -5.8% | 4.4% |
| Net income growth, YoY | -37.9% | 3.4% | -21.4% | -15.8% | 19.8% | -6.2% | 1.3% | 537.6% | 134.4% | 2.2% | -15.6% | -66.9% |
| EPS growth, YoY | -37.5% | 5.3% | -21.4% | -15.3% | 20.0% | -6.9% | 1.4% | 637.5% | 135.3% | 3.1% | -15.9% | -72.4% |
| Gross margin | 86.8% | 88.7% | 87.5% | 87.1% | 86.1% | 90.3% | 88.6% | 88.8% | 87.7% | 89.4% | 89.8% | 87.8% |
| Operating margin | 11.3% | 28.5% | 17.9% | 9.7% | 15.1% | 29.2% | 22.4% | 15.2% | 12.7% | 29.9% | 21.0% | -1.2% |
| Net margin | 9.4% | 24.0% | 15.4% | 16.1% | 14.6% | 24.8% | 19.0% | 19.2% | 13.3% | 26.8% | 21.2% | 3.2% |
| Free cash flow margin | 50.0% | 21.1% | 14.5% | 34.7% | 19.4% | 45.5% | 28.0% | 35.7% | 4.7% | 47.3% | 0.7% | 26.4% |
| Current ratio | 3.19 | 2.98 | 3.17 | 3.17 | 3.44 | 3.04 | 2.91 | 2.86 | 4.14 | 3.50 | 3.68 | 3.52 |
Source: XBRL data Dolby Laboratories files with the SEC, latest filing dated Jul 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| DLB | $1.35B | +0.6% | $226.18M | 16.7% | $6.07B |
| IDCC | $817.25M | -12.0% | $314.90M | 38.5% | $7.35B |
| APPS | $600.31M | +19.2% | -$34.96M | -5.8% | $1.26B |
| ACTG | $273.37M | -3.7% | -$17.84M | -6.5% | $414.7M |
| JYNT | $58.72M | +7.9% | $2.83M | 4.8% | $96.9M |
| AMOD | $7.1K | - | -$8.02M | -112373.7% | $59.3M |
| VHC | $114.0K | +128.0% | -$19.81M | -17373.7% | $40.7M |
| NTIP | $150.0K | +50.0% | -$2.42M | -1613.3% | $36.5M |
| RMCO | $6.17M | +133.5% | -$895.7K | -14.5% | $33.3M |